| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |